Literature DB >> 19903680

Successful eradication of acquired factor-VIII-inhibitor using single low-dose rituximab.

Martin Wermke, Malte von Bonin, Siegmund Gehrisch, Gabriele Siegert, Gerhard Ehninger, Uwe Platzbecker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19903680      PMCID： PMC2833088          DOI： 10.3324/haematol.2009.017749

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  8 in total

Review 1.  Autoimmune hemophilia at rescue.

Authors:  Pier Mannuccio Mannucci; Flora Peyvandi
Journal:  Haematologica       Date:  2009-04       Impact factor: 9.941

2.  Cautions and caveats to the treatment of acquired hemophilia A.

Authors:  Angela Huth-Kühne
Journal:  Haematologica       Date:  2009-08       Impact factor: 9.941

3.  Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation.

Authors:  Peter W Collins; Sybil Hirsch; Trevor P Baglin; Gerard Dolan; John Hanley; Michael Makris; David M Keeling; Ri Liesner; Simon A Brown; Charles R M Hay
Journal:  Blood       Date:  2006-10-17       Impact factor: 22.113

Review 4.  Rituximab in the treatment of adult acquired hemophilia A: a systematic review.

Authors:  Massimo Franchini
Journal:  Crit Rev Oncol Hematol       Date:  2007-01-19       Impact factor: 6.312

5.  Treatment of chronic steroid-refractory graft-versus-host disease with low-dose rituximab.

Authors:  Malte von Bonin; Uta Oelschlägel; Jörgen Radke; Michelle Stewart; Gerhard Ehninger; Martin Bornhauser; Uwe Platzbecker
Journal:  Transplantation       Date:  2008-09-27       Impact factor: 4.939

6.  Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project.

Authors:  Kenneth R Carson; Andrew M Evens; Elizabeth A Richey; Thomas M Habermann; Daniele Focosi; John F Seymour; Jacob Laubach; Susie D Bawn; Leo I Gordon; Jane N Winter; Richard R Furman; Julie M Vose; Andrew D Zelenetz; Ronac Mamtani; Dennis W Raisch; Gary W Dorshimer; Steven T Rosen; Kenji Muro; Numa R Gottardi-Littell; Robert L Talley; Oliver Sartor; David Green; Eugene O Major; Charles L Bennett
Journal:  Blood       Date:  2009-03-05       Impact factor: 22.113

7.  A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies.

Authors:  D Green; A W Rademaker; E Briët
Journal:  Thromb Haemost       Date:  1993-11-15       Impact factor: 5.249

8.  International recommendations on the diagnosis and treatment of patients with acquired hemophilia A.

Authors:  Angela Huth-Kühne; Francesco Baudo; Peter Collins; Jørgen Ingerslev; Craig M Kessler; Hervé Lévesque; Maria Eva Mingot Castellano; Midori Shima; Jean St-Louis
Journal:  Haematologica       Date:  2009-04       Impact factor: 9.941
  8 in total
  7 in total

1.  An unusual cause of bleeding in an elderly patient.

Authors:  Samantha Coulson; Aruchuna Mohanaruban; Abdul Shlebak; Antoni Sergot
Journal:  Clin Med (Lond)       Date:  2012-04       Impact factor: 2.659

Review 2.  Rituximab for eradicating inhibitors in people with acquired haemophilia A.

Authors:  Tracey Remmington; Sherie Smith
Journal:  Cochrane Database Syst Rev       Date:  2021-08-23

3.  Acquired Factor VIII Inhibitor: A Rare Etiology for Bruisability and Anemia.

Authors:  Srikanth Seethala; Keith Barnes; Javier Corral
Journal:  Indian J Hematol Blood Transfus       Date:  2012-07-04       Impact factor: 0.900

Review 4.  The anti-CD20 monoclonal antibody rituximab to treat acquired haemophilia A.

Authors:  Giovanni D'arena; Elvira Grandone; Matteo N D Di Minno; Pellegrino Musto; Giovanni Di Minno
Journal:  Blood Transfus       Date:  2015-09-03       Impact factor: 3.443

5.  A Case of an Acquired Factor VIII Inhibitor Complicated by Multiple Treatment-Related Opportunistic Infections and Review of the Literature.

Authors:  Anna L Hutchinson; Yi Ling Tan; Giselle Kidson-Gerber
Journal:  Case Rep Hematol       Date:  2013-12-18

6.  International recommendations on the diagnosis and treatment of acquired hemophilia A.

Authors:  Andreas Tiede; Peter Collins; Paul Knoebl; Jerome Teitel; Craig Kessler; Midori Shima; Giovanni Di Minno; Roseline d'Oiron; Peter Salaj; Victor Jiménez-Yuste; Angela Huth-Kühne; Paul Giangrande
Journal:  Haematologica       Date:  2020-05-07       Impact factor: 9.941

7.  Reduced-intensity, risk factor-stratified immunosuppression for acquired hemophilia A: single-center observational study.

Authors:  Christiane Dobbelstein; Georgios Leandros Moschovakis; Andreas Tiede
Journal:  Ann Hematol       Date:  2020-07-03       Impact factor: 3.673
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.